South Korea Biopharmaceutical Excipients Market Size & Outlook
Related Markets
South Korea biopharmaceutical excipients market highlights
- The South Korea biopharmaceutical excipients market generated a revenue of USD 55.2 million in 2025 and is expected to reach USD 86.1 million by 2033.
- The South Korea market is expected to grow at a CAGR of 5.8% from 2026 to 2033.
- In terms of segment, solubilizes & surfactants/emulsifiers was the largest revenue generating product in 2025.
- Specialty Excipients is the most lucrative product segment registering the fastest growth during the forecast period.
Biopharmaceutical excipients market data book summary
| Market revenue in 2025 | USD 55.2 million |
| Market revenue in 2033 | USD 86.1 million |
| Growth rate | 5.8% (CAGR from 2026 to 2033) |
| Largest segment | Solubilizes & surfactants/emulsifiers |
| Fastest growing segment | Specialty Excipients |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Specialty Excipients, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates |
| Key market players worldwide | Merck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.7% of the global biopharmaceutical excipients market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China biopharmaceutical excipients market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 176.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Excipients Market Scope
Biopharmaceutical Excipients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| J. Rettenmaier & Söhne | View profile | 101-250 | Holzmühle, Sachsen, Germany, Europe | https://www.jrs.eu |
| DFE Pharma | View profile | 251-500 | Goch, Nordrhein-Westfalen, Germany, Europe | https://www.dfepharma.com/ |
| Sigachi | View profile | 501-1000 | Hyderabad, Andhra Pradesh, India, Asia | https://sigachi.com |
| Spectrum Chemical Manufacturingrp | View profile | 101-250 | New Brunswick, New Jersey, United States, North America | https://www.spectrumchemical.com |
| Colorcon | View profile | 1001-5000 | Harleysville, Pennsylvania, United States, North America | https://www.colorcon.com |
| IMCD NV | View profile | 4948 | Wilhelminaplein 32, Rotterdam, Netherlands, 3072 DE | https://www.imcdgroup.com |
| Roquette America | View profile | 5001-10000 | Gurnee, Illinois, United States, North America | https://www.roquette.com/ |
| Clariant AG | View profile | 10481 | Rothausstrasse 61, Muttenz, Switzerland, 4132 | http://www.clariant.com |
| Associated British Foods PLC | View profile | 133000 | 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY | https://www.abf.co.uk |
| Evonik Industries AG | View profile | 33409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | https://www.evonik.com |
| Basf SE | View profile | 111855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | https://www.basf.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
South Korea biopharmaceutical excipients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.
Solubilizes & surfactants/emulsifiers was the largest segment with a revenue share of 41.3% in 2025. Horizon Databook has segmented the South Korea biopharmaceutical excipients market based on specialty excipients, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2021 to 2033.
In addition, local pharma players such as Dong-A Pharmaceuticals are expanding their operation in biopharma by signing partnership with international companies like Bayer and Meiji.
Key global market players supply their products through subsidiaries or local distributors in South Korea. Daeyeon Chemicals Co. LTD is a distributor of Spectrum Chemical Manufacturing Corp in the country. Identifying the potential opportunities owing to rapid progress of biopharma industry, many international companies are expanding their operations in this market.
Reasons to subscribe to South Korea biopharmaceutical excipients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea biopharmaceutical excipients market databook
-
Our clientele includes a mix of biopharmaceutical excipients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into South Korea biopharmaceutical excipients market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea biopharmaceutical excipients market size, by product, 2021-2033 (US$M)
South Korea Biopharmaceutical Excipients Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
